𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients

✍ Scribed by Dr. Umberto Tirelli; Antonino Carbone; Diana Crivellari; Rachele Volpe; Giovanni Franchin; Andrea Veronesi; Enzo Galligioni; Mauro Trovò; Salvatore Tumolo; Eligio Grigoletto

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
418 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teniposide (VM-26) as a single drug trea
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma : A Phase II study of the Southwest Oncology Group
✍ Petre N. Grozea; John J. Crowley; Vikki A. Canfield; Laura Kingsbury; S. William 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Background: Teniposide (vm-26) was reported to have activity in small cell lung carcinoma (sclc). the authors performed a phase ii study of teniposide as a treatment for patients with previously untreated extensive sclc. ## Methods: The study was open to patients with a histologic or cytologic

Weekly docetaxel in the treatment of eld
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma : A Minnie Pearl Cancer Research Network Phase II Trial
✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Lisa H. Morrissey; Jo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Background: Weekly administration of docetaxel was found to reduce myelosuppression and other nonhematologic toxicities when compared with administration every 3 weeks. in the current phase ii trial, the authors evaluated the feasibility, toxicity, and efficacy of weekly docetaxel in the treatme